{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:26:41Z","timestamp":1788643601164,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T00:00:00Z","timestamp":1706400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T00:00:00Z","timestamp":1706400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Ultrasonics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10396-023-01403-x","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T11:01:46Z","timestamp":1706439706000},"page":"253-260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-687X","authenticated-orcid":false,"given":"Nozomi","family":"Okuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,28]]},"reference":[{"key":"1403_CR1","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","volume":"372","author":"JL Jameson","year":"2015","unstructured":"Jameson JL, Longo DL. Precision medicine\u2013personalized, problematic, and promising. N Engl J Med. 2015;372:2229\u201334.","journal-title":"N Engl J Med."},{"key":"1403_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.19.00291","volume":"3","author":"H Ebi","year":"2019","unstructured":"Ebi H, Bando H. Precision Oncology and the Universal Health Coverage System in Japan. JCO Precis Oncol. 2019;3:1\u201312.","journal-title":"JCO Precis Oncol"},{"key":"1403_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0016-5107(92)70385-X","volume":"38","author":"P Vilmann","year":"1992","unstructured":"Vilmann P, Jacobsen GK, Henriksen FW, et al. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc. 1992;38:172\u20133.","journal-title":"Gastrointest Endosc."},{"key":"1403_CR4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00535-012-0695-8","volume":"48","author":"S Haba","year":"2013","unstructured":"Haba S, Yamao K, Bhatia V, et al. Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience. J Gastroenterol. 2013;48:973\u201381.","journal-title":"J Gastroenterol."},{"key":"1403_CR5","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/cas.13969","volume":"110","author":"K Sunami","year":"2019","unstructured":"Sunami K, Ichikawa H, Kubo T, et al. Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study. Cancer Sci. 2019;110:1480\u201390.","journal-title":"Cancer Sci."},{"key":"1403_CR6","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-020-1063-5","volume":"26","author":"Y Nakamura","year":"2020","unstructured":"Nakamura Y, Taniguchi H, Ikeda M, et al. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies. Nat Med. 2020;26:1859\u201364.","journal-title":"Nat Med."},{"key":"1403_CR7","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41416-019-0457-y","volume":"120","author":"H Bando","year":"2019","unstructured":"Bando H, Kagawa Y, Kato T, et al. A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer. Br J Cancer. 2019;120:982\u20136.","journal-title":"Br J Cancer."},{"key":"1403_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357:409\u201313.","journal-title":"Science."},{"key":"1403_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12885-022-09172-5","volume":"22","author":"H Matsubayashi","year":"2022","unstructured":"Matsubayashi H, Higashigawa S, Kiyozumi Y, et al. Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses. BMC Cancer. 2022;22:73.","journal-title":"BMC Cancer."},{"key":"1403_CR10","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","volume":"21","author":"A Marabelle","year":"2020","unstructured":"Marabelle A, Fakih M, Lopez J, et al. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol. 2020;21:1353\u201365.","journal-title":"Lancet Oncol."},{"key":"1403_CR11","doi-asserted-by":"publisher","first-page":"175883592199299","DOI":"10.1177\/1758835921992992","volume":"13","author":"H Kim","year":"2021","unstructured":"Kim H, Hong JY, Lee J, et al. Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors. Ther Adv Med Oncol. 2021;13:1758835921992992.","journal-title":"Ther Adv Med Oncol."},{"key":"1403_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/genes1030413","volume":"1","author":"A Borchers","year":"2010","unstructured":"Borchers A, Pieler T. Programming pluripotent precursor cells derived from Xenopus embryos to generate specific tissues and organs. Genes (Basel). 2010;1:413\u201326.","journal-title":"Genes (Basel)."},{"key":"1403_CR13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1158\/1541-7786.MCR-17-0735","volume":"16","author":"ME Salem","year":"2018","unstructured":"Salem ME, Puccini A, Grothey A, et al. Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers. Mol Cancer Res. 2018;16:805\u201312.","journal-title":"Mol Cancer Res."},{"key":"1403_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","volume":"21","author":"RC Doebele","year":"2020","unstructured":"Doebele RC, Drilon A, Paz-Ares L, et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1\u20132 trials. The Lancet Oncology. 2020;21:271\u201382.","journal-title":"The Lancet Oncology."},{"key":"1403_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.18.00183","volume":"2","author":"R Okamura","year":"2018","unstructured":"Okamura R, Boichard A, Kato S, et al. Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics. JCO Precis Oncol. 2018;2:1\u201320.","journal-title":"JCO Precis Oncol"},{"key":"1403_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1634\/theoncologist.2013-0352","volume":"19","author":"JS Ross","year":"2014","unstructured":"Ross JS, Wang K, Gay L, et al. New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing. Oncologist. 2014;19:235\u201342.","journal-title":"Oncologist."},{"key":"1403_CR17","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1164368","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321:1801\u20136.","journal-title":"Science."},{"key":"1403_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518:495\u2013501.","journal-title":"Nature."},{"key":"1403_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","volume":"16","author":"EA Collisson","year":"2019","unstructured":"Collisson EA, Bailey P, Chang DK, et al. Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2019;16:207\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"1403_CR20","first-page":"60","volume":"7","author":"B Friedenson","year":"2005","unstructured":"Friedenson B. BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. MedGenMed. 2005;7:60.","journal-title":"MedGenMed."},{"key":"1403_CR21","doi-asserted-by":"publisher","first-page":"10778","DOI":"10.3748\/wjg.v20.i31.10778","volume":"20","author":"P Ghiorzo","year":"2014","unstructured":"Ghiorzo P. Genetic predisposition to pancreatic cancer. World J Gastroenterol. 2014;20:10778\u201389.","journal-title":"World J Gastroenterol."},{"key":"1403_CR22","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1200\/JCO.2014.59.7401","volume":"33","author":"S Holter","year":"2015","unstructured":"Holter S, Borgida A, Dodd A, et al. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma. J Clin Oncol. 2015;33:3124\u20139.","journal-title":"J Clin Oncol."},{"key":"1403_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan T, Hammel P, Reni M, et al. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. N Engl J Med. 2019;381:317\u201327.","journal-title":"N Engl J Med."},{"key":"1403_CR24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.02.037","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi AD, George B, Greenbowe JR, et al. Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. Gastroenterology. 2019;156:e4.","journal-title":"Gastroenterology."},{"key":"1403_CR25","unstructured":"Japanese Organization of Hereditary Breast and Ovarian Cancer. Guideline for diagnosis and treatment of hereditary breast and ovarian cancer 2021. https:\/\/johboc.jp\/guidebook_2021\/."},{"key":"1403_CR26","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1158\/1078-0432.CCR-18-0531","volume":"24","author":"MJ Pishvaian","year":"2018","unstructured":"Pishvaian MJ, Bender RJ, Halverson D, et al. Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. Clin Cancer Res. 2018;24:5018\u201327.","journal-title":"Clin Cancer Res."},{"key":"1403_CR27","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1158\/1078-0432.CCR-20-0418","volume":"26","author":"W Park","year":"2020","unstructured":"Park W, Chen J, Chou JF, et al. Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection. Clin Cancer Res. 2020;26:3239\u201347.","journal-title":"Clin Cancer Res."},{"key":"1403_CR28","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","volume":"383","author":"DS Hong","year":"2020","unstructured":"Hong DS, Fakih MG, Strickler JH, et al. KRAS(G12C) Inhibition with Sotorasib in Advanced Solid Tumors. N Engl J Med. 2020;383:1207\u201317.","journal-title":"N Engl J Med."},{"key":"1403_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00535-012-0664-2","volume":"48","author":"T Ogura","year":"2013","unstructured":"Ogura T, Yamao K, Hara K, et al. Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer. J Gastroenterol. 2013;48:640\u20136.","journal-title":"J Gastroenterol."},{"key":"1403_CR30","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/cncr.29364","volume":"121","author":"H Kinugasa","year":"2015","unstructured":"Kinugasa H, Nouso K, Miyahara K, et al. Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer. Cancer. 2015;121:2271\u201380.","journal-title":"Cancer."},{"key":"1403_CR31","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.18632\/oncotarget.28021","volume":"12","author":"Y Okawa","year":"2021","unstructured":"Okawa Y, Ebata N, Kim NKD, et al. Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase. Oncotarget. 2021;12:1540\u201352.","journal-title":"Oncotarget."},{"key":"1403_CR32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Arai Y, Totoki Y, et al. Genomic spectra of biliary tract cancer. Nat Genet. 2015;47:1003\u201310.","journal-title":"Nat Genet."},{"key":"1403_CR33","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","volume":"68","author":"CP Wardell","year":"2018","unstructured":"Wardell CP, Fujita M, Yamada T, et al. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J Hepatol. 2018;68:959\u201369.","journal-title":"J Hepatol."},{"key":"1403_CR34","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/hep.26890","volume":"59","author":"Y Arai","year":"2014","unstructured":"Arai Y, Totoki Y, Hosoda F, et al. Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. Hepatology. 2014;59:1427\u201334.","journal-title":"Hepatology."},{"key":"1403_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Sahai V, Hollebecque A, et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2020;21:671\u201384.","journal-title":"Lancet Oncol."},{"key":"1403_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa2206834","volume":"388","author":"L Goyal","year":"2023","unstructured":"Goyal L, Meric-Bernstam F, Hollebecque A, et al. Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma. N Engl J Med. 2023;388:228\u201339.","journal-title":"N Engl J Med."},{"key":"1403_CR37","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Macarulla T, Javle MM, et al. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol. 2020;21:796\u2013807.","journal-title":"Lancet Oncol."},{"key":"1403_CR38","doi-asserted-by":"publisher","first-page":"751","DOI":"10.21037\/jgo.2019.03.10","volume":"10","author":"AN Boscoe","year":"2019","unstructured":"Boscoe AN, Rolland C, Kelley RK. Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review. J Gastrointest Oncol. 2019;10:751\u201365.","journal-title":"J Gastrointest Oncol."},{"key":"1403_CR39","unstructured":"Foundation Medicine Inc. FoundationOne CDx. Specimen in-structions [Internet]. Cambridge: Foundation Medicine Inc.; 2021. https:\/\/www.foundationmedicine.be\/content\/dam\/rfm\/be_v2-en_be\/F1CDx%20specimen%20instructions.pdf. Cited 2022 Feb 22."},{"key":"1403_CR40","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/ajg.2010.108","volume":"105","author":"TJ Song","year":"2010","unstructured":"Song TJ, Kim JH, Lee SS, et al. The prospective randomized, controlled trial of endoscopic ultrasound-guided fine-needle aspiration using 22G and 19G aspiration needles for solid pancreatic or peripancreatic masses. Am J Gastroenterol. 2010;105:1739\u201345.","journal-title":"Am J Gastroenterol."},{"key":"1403_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1055\/s-0031-1291543","volume":"44","author":"M Polkowski","year":"2012","unstructured":"Polkowski M, Larghi A, Weynand B, et al. Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline. Endoscopy. 2012;44:190\u2013206.","journal-title":"Endoscopy."},{"key":"1403_CR42","doi-asserted-by":"publisher","first-page":"E363","DOI":"10.1055\/s-0043-101693","volume":"5","author":"MA Khan","year":"2017","unstructured":"Khan MA, Grimm IS, Ali B, et al. A meta-analysis of endoscopic ultrasound-fine-needle aspiration compared to endoscopic ultrasound-fine-needle biopsy: diagnostic yield and the value of onsite cytopathological assessment. Endosc Int Open. 2017;5:E363\u201375.","journal-title":"Endosc Int Open."},{"key":"1403_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12328-020-01153-0","volume":"13","author":"A Chhoda","year":"2020","unstructured":"Chhoda A, Rustagi T. EUS-guided needle biopsy for autoimmune pancreatitis. Clin J Gastroenterol. 2020;13:669\u201377.","journal-title":"Clin J Gastroenterol."},{"key":"1403_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2020.02.021","volume":"92","author":"DTH de Moura","year":"2020","unstructured":"de Moura DTH, McCarty TR, Jirapinyo P, et al. EUS-guided fine-needle biopsy sampling versus FNA in the diagnosis of subepithelial lesions: a large multicenter study. Gastrointest Endosc. 2020;92(108\u201319): e3.","journal-title":"Gastrointest Endosc."},{"key":"1403_CR45","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/MPA.0000000000001117","volume":"47","author":"BK Larson","year":"2018","unstructured":"Larson BK, Tuli R, Jamil LH, et al. Utility of Endoscopic Ultrasound-Guided Biopsy for Next-Generation Sequencing of Pancreatic Exocrine Malignancies. Pancreas. 2018;47:990\u20135.","journal-title":"Pancreas."},{"key":"1403_CR46","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/jgh.14540","volume":"34","author":"S Elhanafi","year":"2019","unstructured":"Elhanafi S, Mahmud N, Vergara N, et al. Comparison of endoscopic ultrasound tissue acquisition methods for genomic analysis of pancreatic cancer. J Gastroenterol Hepatol. 2019;34:907\u201313.","journal-title":"J Gastroenterol Hepatol."},{"key":"1403_CR47","doi-asserted-by":"publisher","first-page":"e0228565","DOI":"10.1371\/journal.pone.0228565","volume":"15","author":"T Ishizawa","year":"2020","unstructured":"Ishizawa T, Makino N, Matsuda A, et al. Usefulness of rapid on-site evaluation specimens from endoscopic ultrasound-guided fine-needle aspiration for cancer gene panel testing: A retrospective study. PLoS One. 2020;15:e0228565.","journal-title":"PLoS One."},{"key":"1403_CR48","first-page":"376","volume":"53","author":"P Kandel","year":"2020","unstructured":"Kandel P, Nassar A, Gomez V, et al. Comparison of endoscopic ultrasound-guided fine-needle biopsy versus fine-needle aspiration for genomic profiling and DNA yield in pancreatic cancer: a randomized crossover trial. Endoscopy. 2020;53:376\u201382.","journal-title":"Endoscopy"},{"key":"1403_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5009\/gnl19011","volume":"14","author":"JK Park","year":"2020","unstructured":"Park JK, Lee JH, Noh DH, et al. Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma. Gut Liver. 2020;14:387\u201394.","journal-title":"Gut Liver."},{"key":"1403_CR50","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.gie.2020.06.069","volume":"93","author":"S Carrara","year":"2021","unstructured":"Carrara S, Solda G, Di Leo M, et al. Side-by-side comparison of next-generation sequencing, cytology, and histology in diagnosing locally advanced pancreatic adenocarcinoma. Gastrointest Endosc. 2021;93:e5.","journal-title":"Gastrointest Endosc."},{"key":"1403_CR51","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s00535-022-01926-z","volume":"57","author":"Y Hisada","year":"2022","unstructured":"Hisada Y, Hijioka S, Ikeda G, et al. Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide NCC Oncopanel System analysis suitability criteria: a single-arm, phase II clinical trial. J Gastroenterol. 2022;57:990\u20138.","journal-title":"J Gastroenterol."},{"key":"1403_CR52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/den.14423","volume":"35","author":"G Ikeda","year":"2023","unstructured":"Ikeda G, Hijioka S, Nagashio Y, et al. Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for genomic profiling of unresectable pancreatic cancer. Dig Endosc. 2023;35:124\u201333.","journal-title":"Dig Endosc."},{"key":"1403_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5946\/ce.2022.086","volume":"56","author":"N Okuno","year":"2023","unstructured":"Okuno N, Hara K, Mizuno N, et al. Clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling of pancreatic cancer. Clin Endosc. 2023;56:221\u20138.","journal-title":"Clin Endosc."},{"key":"1403_CR54","doi-asserted-by":"publisher","first-page":"e00022","DOI":"10.14309\/ctg.0000000000000022","volume":"10","author":"K Hirata","year":"2019","unstructured":"Hirata K, Kuwatani M, Suda G, et al. A Novel Approach for the Genetic Analysis of Biliary Tract Cancer Specimens Obtained Through Endoscopic Ultrasound-Guided Fine Needle Aspiration Using Targeted Amplicon Sequencing. Clin Transl Gastroenterol. 2019;10:e00022.","journal-title":"Clin Transl Gastroenterol."},{"key":"1403_CR55","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jgh3.12576","volume":"5","author":"Y Kai","year":"2021","unstructured":"Kai Y, Ikezawa K, Takada R, et al. Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer. JGH Open. 2021;5:712\u20136.","journal-title":"JGH Open."},{"key":"1403_CR56","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1007\/s10620-021-07138-4","volume":"67","author":"SB Yoon","year":"2021","unstructured":"Yoon SB, Moon SH, Ko SW, et al. Brush Cytology, Forceps Biopsy, or Endoscopic Ultrasound-Guided Sampling for Diagnosis of Bile Duct Cancer: A Meta-Analysis. Dig Dis Sci. 2021;67:3284\u201397.","journal-title":"Dig Dis Sci."},{"key":"1403_CR57","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/gutjnl-2018-317817","volume":"69","author":"AD Singhi","year":"2020","unstructured":"Singhi AD, Nikiforova MN, Chennat J, et al. Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Gut. 2020;69:52\u201361.","journal-title":"Gut."},{"key":"1403_CR58","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/den.13912","volume":"33","author":"A Kanno","year":"2021","unstructured":"Kanno A, Yasuda I, Irisawa A, et al. Adverse events of endoscopic ultrasound-guided fine-needle aspiration for histologic diagnosis in Japanese tertiary centers: Multicenter retrospective study. Dig Endosc. 2021;33:1146\u201357.","journal-title":"Dig Endosc."}],"container-title":["Journal of Medical Ultrasonics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10396-023-01403-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10396-023-01403-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10396-023-01403-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T06:10:33Z","timestamp":1715839833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10396-023-01403-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,28]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1403"],"URL":"https:\/\/doi.org\/10.1007\/s10396-023-01403-x","relation":{},"ISSN":["1346-4523","1613-2254"],"issn-type":[{"value":"1346-4523","type":"print"},{"value":"1613-2254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,28]]},"assertion":[{"value":"21 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nozomi Okuno declares that she has no conflict of interest. Kazuo Hara declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research related to human use complied with all the relevant national regulations and institutional policies and was conducted in accordance with the tenets of the Helsinki Declaration of 1964 and later versions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}